Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00320801
Other study ID # BUP3014 and BUP3014S
Secondary ID
Status Terminated
Phase Phase 3
First received April 28, 2006
Last updated August 27, 2012
Start date January 2004
Est. completion date March 2005

Study information

Verified date August 2012
Source Purdue Pharma LP
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The original objective of this study was to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (BTDS) 20 micrograms (mcg)/hour (h) in comparison to the buprenorphine transdermal system 5 mcg/h in subjects with moderate to severe osteoarthritis pain currently treated with oral opioids. The double-blind treatment intervention duration is 12 weeks during which time supplemental analgesic medication (acetaminophen or ibuprofen) will be provided to all subjects in addition to study drug.

This study was terminated early due to administrative reasons with only 20% of the planned sample size; therefore, the primary objective was changed to focus on the safety evaluation.


Description:

Buprenorphine is a synthetic opioid analgesic with over 25 years of international clinical experience indicating it to be safe and effective in a variety of therapeutic situations for the relief of moderate to severe pain.


Other known NCT identifiers
  • NCT01137422

Recruitment information / eligibility

Status Terminated
Enrollment 188
Est. completion date March 2005
Est. primary completion date March 2005
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- osteoarthritis of the hip, knee, or spine for 1 year or longer.

- taking between 30-80 milligrams (mg) of oral morphine sulfate or equivalent/day, at least 4 days a week.

Exclusion Criteria:

- taking more than 80 mg per day of oral morphine sulfate or equivalent within 30 days of enrollment.

- requiring frequent analgesic therapy for chronic conditions in addition to osteoarthritis.

Other protocol-specific exclusion/inclusion criteria may apply.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Buprenorphine transdermal patch
Buprenorphine transdermal patch 5 mcg/h applied for 7-day wear
Buprenorphine transdermal patch
Buprenorphine transdermal patch 20 mcg/h applied for 7-day wear

Locations

Country Name City State
United States Keystone Clinical Solutions, Inc. Altoona Pennsylvania
United States Crest Clinical Research, Inc Anaheim California
United States NuLife Clinical Research, Inc. Anaheim California
United States Arthritis Clinic of No. Virginia Arlington Virginia
United States Private Practice Arvada Colorado
United States Crescent Medical Assoc. Astoria New York
United States Pinnacle Trials, Inc. Atlanta Georgia
United States Clinical Investigative Services Med College of Georgia Augusta Georgia
United States Private Practice Aventura Florida
United States Midwest Regional Research Bellbrook Ohio
United States Comprehensive Clinical Research Berlin New Jersey
United States Edwards Lake Medical Center Birmingham Alabama
United States Parkway Medical Center Birmingham Alabama
United States Odyssey Research Services Bismark North Dakota
United States Professional Clinical Research Cadillac Michigan
United States Charlotte Spine Center Pain and Orthopedic Neurology, Pain Research Institute of the Carolinas Charlotte North Carolina
United States Cherry Hill Orthopedic Surgeons Cherry Hill New Jersey
United States Alpha Clinical Research Clarksville Tennessee
United States Medical Research Associates Clearwater Florida
United States Orange County Clinical Research Cypress California
United States Mountainview Clinical Research Denver Colorado
United States Albermarle Family Practice Elizabeth City North Carolina
United States Research Center of the Ozarks, , MO Everton Missouri
United States America's Doctor (SMO) Gurnee Illinois
United States Central Arkansas Research Hot Springs Arkansas
United States Rheumatogogy Associates of N. Alabama, Huntsville Alabama
United States Holston Medical Group Kingsport Tennessee
United States Vantage Clinical Research Group Lacey Washington
United States Private Practice Laguna Hills California
United States Andwell Research Laguna Niguel California
United States Valerius Medical Group & Research Center Inc. Long Beach California
United States Anesthesiology and Pain Management Los Gatos California
United States Private Practice Medford New Jersey
United States Rouge Valley Clinical Research Medford Oregon
United States Southern Oregon Health & Wellness Medford Oregon
United States LifeSpan Clinical Research Miami Florida
United States Integrity Clinical Research, LLC (SMO) Milan Tennessee
United States Drug Research and Analysis Corp. Montgomery Alabama
United States Dolby Providers, Inc. New Orleans Louisiana
United States Private Practice Oak Park Michigan
United States Ocala Rheumatology Research Center Ocala Florida
United States COR Clinical Research, LLC Oklahoma City Oklahoma
United States The Arthritis & Osteoporosis Center Orangeburg South Carolina
United States Arcuri Clinical Research Philadelphia Pennsylvania
United States Sidney Hillman Medical Center Philadelphia Pennsylvania
United States Private Practice Plainview New York
United States MedSource Richmond Virginia
United States J. Lewis Research Foothill Family Clinic Salt Lake City Utah
United States J. Lewis Research Foothill Family Clinic South Salt Lake City Utah
United States LifeTree Clinical Reseach Salt Lake City Utah
United States Scripps Clinic Ranchro Bernardo San Diego California
United States Orrin M. Troum & Medical Associates Santa Monica California
United States Sarasota Arthritis Center Sarasota Florida
United States University Neurology Sarasota Florida
United States Meadowbrook Research Scottsdale Arizona
United States Research Solutions, LLC Searcy Arizona
United States Arthritis Northwest Seattle Washington
United States Family Practice of St. Cloud PA Wilker/Powers Center for Clinical Studies St. Cloud Florida
United States Wilker/Powers Center for Clinical Studies St. Cloud Florida
United States Lake Michigan Clinical Research and Consulting, Inc. St. Joseph Michigan
United States State University of NY at Stonybrook Stonybrook New York
United States Univeristy of Medicine and Dentistry of New Jersey Stratford New Jersey
United States Lyle, Austin Alexander PA Tulsa Oklahoma
United States Diablo Clinical Research Walnut Creek California
United States New Hanover Medical Research Wilmington North Carolina
United States Clinical Trials Northwest Yakima Washington

Sponsors (1)

Lead Sponsor Collaborator
Purdue Pharma LP

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Number of Participants With Adverse Events (AEs) as a Measure of Safety. Safety assessments included monitoring and recording of all adverse events and serious adverse events (SAEs). Throughout BTDS exposure (Includes run-in period, double-blind phase and extension phase) Yes
See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A

External Links